Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10696)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 14, 2017 (publication date) through Oct 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World J Gastroenterol 2017; 23(46): 8235-8247 [PMID: 29290660 DOI: 10.3748/wjg.v23.i46.8235] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i46/8235.htm |
| Number | Citing Articles |
| 1 |
Friederike Cordes, Claudia Demmig, Arne Bokemeyer, Markus Brückner, Frank Lenze, Philipp Lenz, Tobias Nowacki, Phil Tepasse, Hartmut H. Schmidt, M. Alexander Schmidt, Christoph Cichon, Dominik Bettenworth. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 2020; 11(3): e00134 doi: 10.14309/ctg.0000000000000134
|
| 2 |
Nader D Daoud, Jana G Hashash, Michael F Picco, Francis A Farraye. Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn’s Disease. Journal of Crohn's and Colitis 2022; 16(4): 601 doi: 10.1093/ecco-jcc/jjab182
|
| 3 |
Ahmed Bahaa, Tamer Elbaz, Hesham Elmakhzangy, Mohammed Shehata, Dalia Abd El-Kareem, AbdelAziz Gaber, Mohamed B. Hashem, Maissa El Raziky. Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices. Arab Journal of Gastroenterology 2024; 25(3): 299 doi: 10.1016/j.ajg.2024.07.003
|
| 4 |
Tomoya Sugiyama, Makoto Sasaki, Shoko Nakagawa, Satoshi Inoue, Kazunori Adachi, Takashi Yoshimine, Yoshiharu Yamaguchi, Yasuhiro Tamura, Shinya Izawa, Yasutaka Hijikata, Masahide Ebi, Mari Mizuno, Sayuri Yamamoto, Yasushi Funaki, Naotaka Ogasawara, Chiho Goto, Kunio Kasugai. The association among enterobacterial flora, dietary factors, and prognosis in patients with ulcerative colitis. Journal of Clinical Biochemistry and Nutrition 2020; 66(2): 152 doi: 10.3164/jcbn.19-90
|
| 5 |
Dora Grgić, Karlo Golubić, Marko Brinar, Željko Krznarić. Predictive value of faecal calprotectin in ulcerative colitis – single centre experience. Annals of Medicine 2022; 54(1): 1570 doi: 10.1080/07853890.2022.2082518
|
| 6 |
Giulia D'Arcangelo, Salvatore Oliva, Anna Dilillo, Franca Viola, Fortunata Civitelli, Sara Isoldi, Salvatore Cucchiara, Marina Aloi. Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab. Journal of Pediatric Gastroenterology and Nutrition 2019; 68(6): 841 doi: 10.1097/MPG.0000000000002262
|
| 7 |
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer. Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 2020; 10(6): 367 doi: 10.3390/diagnostics10060367
|
| 8 |
Robert Battat, William J. Sandborn. Advances in the Comprehensive Management of Postoperative Crohn’s Disease. Clinical Gastroenterology and Hepatology 2022; 20(7): 1436 doi: 10.1016/j.cgh.2021.03.048
|
| 9 |
Klaus R. Herrlinger, Eduard F. Stange. To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease. Expert Review of Gastroenterology & Hepatology 2023; 17(12): 1205 doi: 10.1080/17474124.2023.2296564
|
| 10 |
Jun Kato, Takeichi Yoshida, Sakiko Hiraoka. Prediction of treatment outcome and relapse in inflammatory bowel disease. Expert Review of Clinical Immunology 2019; 15(6): 667 doi: 10.1080/1744666X.2019.1593140
|
| 11 |
Ashish R Srinivasan. Treat to target in Crohn’s disease: A practical guide for clinicians. World Journal of Gastroenterology 2024; 30(1): 50-69 doi: 10.3748/wjg.v30.i1.50
Abstract(334) |
Core Tip(344) |
Full Article(HTML)(4538)
|
Full Article with Cover (PDF)-2334K(148)
|
Full Article (Word)-573K(24)
|
Audio-403K(12)
|
Peer-Review Report-232K(38)
|
Answering Reviewers-60K(39)
|
Full Article (PDF)-922K(477)
|
Full Article (XML)-347K(38)
|
Times Cited (6)
|
Total Visits (7000)
|
Open
|
| 12 |
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment. European Journal of Gastroenterology & Hepatology 2020; 32(9): 1091 doi: 10.1097/MEG.0000000000001731
|
| 13 |
Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński, Małgorzata Krzystek-Korpacka. Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine 2021; 10(10): 2203 doi: 10.3390/jcm10102203
|
| 14 |
Cong Dai, Min Jiang, Ming-Jun Sun. Fecal markers in the management of inflammatory bowel disease. Postgraduate Medicine 2018; 130(7): 597 doi: 10.1080/00325481.2018.1503919
|
| 15 |
Lina María Martínez-López, Alexis Perez-Gonzalez, Elizabeth Ann Washington, Andrew P. Woodward, Alexandra Jazmin Roth-Schulze, Julien R. S. Dandrieux, Thurid Johnstone, Nathalee Prakash, Aaron Jex, Caroline Mansfield, Franck Carbonero. Hierarchical modelling of immunoglobulin coated bacteria in dogs with chronic enteropathy shows reduction in coating with disease remission but marked inter-individual and treatment-response variability. PLOS ONE 2021; 16(8): e0255012 doi: 10.1371/journal.pone.0255012
|
| 16 |
Joel Tan Joel Tan, Teresa Neeman, Kavitha Subramaniam Kavitha Subramaniam. The utility of serum anti-tumour necrosis factor levels and biomarkers in predicting endoscopic activity in inflammatory bowel disease. Gastroenterology & Hepatology: Open Access 2022; 13(2): 53 doi: 10.15406/ghoa.2022.13.00494
|
| 17 |
Anuj Bohra, Ghada Mohamed, Abhinav Vasudevan, Diana Lewis, Daniel R. Van Langenberg, Jonathan P. Segal. The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis. Biomedicines 2023; 11(5): 1408 doi: 10.3390/biomedicines11051408
|
| 18 |
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 2018; 24(33): 3681-3694 doi: 10.3748/wjg.v24.i33.3681
|
| 19 |
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem Bemelman, Silvio Danese, Jean Yves Mary, David Rubin, Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Iris Dotan, Maria T. Abreu, Axel Dignass. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021; 160(5): 1570 doi: 10.1053/j.gastro.2020.12.031
|
| 20 |
Kun He, Dong Wu. The treatment principles and targets for intestinal Behcet’s disease. Therapeutic Advances in Gastroenterology 2023; 16: 175628482311672 doi: 10.1177/17562848231167283
|
| 21 |
Jingwen Pei, Guobing Wang, Yi Li, Lan Li, Chang Li, Yu Wu, Jinbo Liu, Gang Tian. Utility of four machine learning approaches for identifying ulcerative colitis and Crohn's disease. Heliyon 2024; 10(1): e23439 doi: 10.1016/j.heliyon.2023.e23439
|
| 22 |
Meng-Hui Zhang, Han Wang, Hong-Gang Wang, Xin Wen, Xiao-Zhong Yang. Effective immune-inflammation index for ulcerative colitis and activity assessments. World Journal of Clinical Cases 2021; 9(2): 334-343 doi: 10.12998/wjcc.v9.i2.334
|
| 23 |
Lidia Neamți, Tudor Drugan, Cristina Drugan, Ciprian Silaghi, Lidia Ciobanu, Alexandra Crăciun. An Improved Score for the Evaluation of Mucosal Healing in Inflammatory Bowel Disease—A Pilot Study. Journal of Clinical Medicine 2023; 12(4): 1663 doi: 10.3390/jcm12041663
|
| 24 |
Qingyang Zhou, Qingli Zhu, Wei Liu, Wenbo Li, Li Ma, Mengsu Xiao, Jingjuan Liu, Hong Yang, Jiaming Qian. New score models for assessing disease activity in Crohn's disease based on bowel ultrasound and biomarkers: Ideal surrogates for endoscopy or imaging. Clinical and Translational Science 2023; 16(9): 1639 doi: 10.1111/cts.13575
|
| 25 |
Katarzyna Akutko, Barbara Iwańczak. Evaluation of Fecal Calprotectin, Serum C-Reactive Protein, Erythrocyte Sedimentation Rate, Seromucoid and Procalcitonin in the Diagnostics and Monitoring of Crohn’s Disease in Children. Journal of Clinical Medicine 2022; 11(20): 6086 doi: 10.3390/jcm11206086
|
| 26 |
Bailu Geng, Xueli Ding, Xiaoyu Li, Hua Liu, Wenjun Zhao, Haihong Gong, Zibin Tian, Jing Guo. Peripheral blood T-lymphocyte subsets are potential biomarkers of disease severity and clinical outcomes in patients with ulcerative colitis: a retrospective study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02769-5
|
| 27 |
Min Zhu, Jing-Xi Mu, Ming-Shan Jiang, Arjudeb Mukherjee, Zhen Zeng, Yi-Ding Chen, Xiao-Li Yang, Hu Zhang. Chinese research into ulcerative colitis from 1978 to 2017: A bibliometric analysis. World Journal of Meta-Analysis 2020; 8(2): 163-172 doi: 10.13105/wjma.v8.i2.163
|
| 28 |
Parambir S. Dulai, Robert Battat, Maria Barsky, Nghia H. Nguyen, Christopher Ma, Neeraj Narula, Mahmoud Mosli, Niels Vande Casteele, Brigid S. Boland, Larry Prokop, M. Hassan Murad, Geert D'Haens, Brian G. Feagan, William J. Sandborn, Vipul Jairath, Siddharth Singh. Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors. American Journal of Gastroenterology 2020; 115(6): 885 doi: 10.14309/ajg.0000000000000596
|
| 29 |
Sophie Restellini, Che-Yung Chao, Myriam Martel, Alan Barkun, Omar Kherad, Ernest Seidman, Gary Wild, Alain Bitton, Waqqas Afif, Talat Bessissow, Peter L. Lakatos. Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review. Clinical Gastroenterology and Hepatology 2019; 17(7): 1265 doi: 10.1016/j.cgh.2018.12.021
|
| 30 |
Eran Zittan, Ian M. Gralnek, Marc S. Berns. The New Proactive Approach and Precision Medicine in Crohn’s Disease. Biomedicines 2020; 8(7): 193 doi: 10.3390/biomedicines8070193
|
| 31 |
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis. PLOS ONE 2019; 14(10): e0223893 doi: 10.1371/journal.pone.0223893
|
| 32 |
Marco Daperno, Alessandro Armuzzi, Silvio Danese, Walter Fries, Giuseppina Liguori, Ambrogio Orlando, Claudio Papi, Mariabeatrice Principi, Fernando Rizzello, Angelo Viscido, Paolo Gionchetti. Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/3108025
|
| 33 |
Timna Naftali, Adi Eindor-Abarbanel, Nahum Ruhimovich, Ariella Bar-Gil Shitrit, Fabiana Sklerovsky-Benjaminov, Fred Konikoff, Shay Matalon, Haim Shirin, Yael Milgrom, Tomer Ziv-Baran, Efrat Broide. The Relationship between Gender, Severity of Disease, Treatment Type, and Employment Outcome in Patients with Inflammatory Bowel Disease in Israel. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/5090849
|
| 34 |
Nicola Cesaro, Marco Valvano, Sabrina Monaco, Gianpiero Stefanelli, Stefano Fabiani, Filippo Vernia, Stefano Necozione, Angelo Viscido, Giovanni Latella. The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology 2024; doi: 10.1097/MEG.0000000000002842
|
| 35 |
Shuling Wang, Guangyu Tang, Shuaishuai Liu, Yun Tu, Rui Ji, Rui Tang, Ting Hua, Jingqi Zhu. Comparison of the value of adipose tissues in abdomen and lumbar vertebra for predicting disease activity in Crohn's disease: A preliminary study based on CSE-MRI. Magnetic Resonance Imaging 2024; 112: 1 doi: 10.1016/j.mri.2024.06.001
|
| 36 |
Seyed-Javad Pournaghi, Hamid Jamialahmadi, Hadis Pazhohan-Nezhad, Meysam Moghbeli, Amin Saburi, Fatemeh Eghbal, Ailar Nakhlband, Ehsan Saburi. Procalcitonin in inflammatory bowel disease: A diagnostic or prognostic marker. Pathology - Research and Practice 2024; 262: 155548 doi: 10.1016/j.prp.2024.155548
|